Figure 3From: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis Meta-analysis examining preoperative chemotherapy and surgery compared to surgery alone: mortality at one year. Overall risk ratio = 1.00 (95% CI, 0.83 to 1.19; p = 0.98)Back to article page